Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Mise à jour : Il y a 4 ans
Référence : NCT01431638

Femme et Homme

Extrait

This is a 36 week open-label extension of the canakinumab pre-filled syringe study for safety and tolerability in patients who have frequent flares of acute gouty arthritis.


Critère d'inclusion

  • Acute Gouty Arthritis


Liens